Strides receives USFDA approval for Ethacrynic Acid Tablets

Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Ltd, Singapore, has received approval for Ethacrynic Acid Tablets USP, 25 mg from the United States Food& Drug Administration (USFDA).
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news